Related Experiment Videos
bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas
B R Smoller1, M Van de Rijn, D Lebrun
1Department of Pathology, Stanford University Medical Center, CA 94305.
The British Journal of Dermatology
|July 1, 1994
Summary
Distinguishing trichoepitheliomas (TE) from basal cell carcinomas (BCC) is crucial. Bcl-2 staining patterns can help differentiate these follicular neoplasms, aiding diagnosis and treatment.
Area of Science:
- Dermatopathology
- Oncology
- Molecular Biology
Background:
- Trichoepitheliomas (TE) are benign follicular neoplasms.
- Basal cell carcinomas (BCC) are malignant neoplasms.
- TE and BCC share similar clinical presentations, necessitating accurate diagnostic methods.
Purpose of the Study:
- To investigate the utility of bcl-2 oncoprotein expression in differentiating TE from BCC.
- To establish a reliable immunohistochemical marker for distinguishing these two entities.
Main Methods:
- Immunohistochemical staining of formalin-fixed, paraffin-embedded specimens of TE and BCC using anti-bcl-2 antibodies.
- Analysis of bcl-2 staining patterns in unequivocal and equivocal cases.
Main Results:
- Trichoepithelioma cells exhibited peripheral bcl-2 staining.
- Basal cell carcinoma cells showed diffuse bcl-2 staining throughout the tumor nodules.
- The distinct staining patterns effectively differentiated between TE and BCC.
Conclusions:
- Bcl-2 immunohistochemistry is a valuable tool for distinguishing between trichoepitheliomas and basal cell carcinomas.
- This diagnostic aid can improve patient management by clarifying treatment and prognosis.
- The differential expression of bcl-2 may reflect underlying biological differences between TE and BCC.